Opinion
The Breakthrough Drug Whose Full Promise Remains Unrealized
- Author:
- Nancy S. Reau, MD
Publish date: January 26, 2024
With its approval in 2013, sofosbuvir revolutionized the treatment of hepatitis C, but the goal of eliminating this disease is still decades away...
Opinion
MASLD: Promising treatments for a newly renamed disease
- Author:
- Sujit V. Janardhan, MD, PhD
- Nancy S. Reau, MD
Publish date: September 15, 2023
The name change refocuses the attention of providers on the fundamental basis of MASLD as a critical member of the metabolic syndrome spectrum of...
Opinion
HCV screening in pregnancy: Reducing the risk for casualties in the quest for elimination
- Author:
- Nancy S. Reau, MD
- Luis D. Pacheco, MD
Publish date: November 23, 2021
HCV screening during pregnancy, as currently recommended, provides no immediate benefit for the pregnant woman or the fetus/neonate, given that...
Opinion
Vanquishing hepatitis C: A remarkable success story
- Author:
- Donald M. Jensen, MD
- Nancy S. Reau, MD
Publish date: November 20, 2020
It only took 25 years between the discovery of the HCV in 1989 to its eventual cure in 2014.